Clinical Guidance Category

Present On Admission Exempt Codes

ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2026 CMS POA exempt list.

Linked Diagnostic CodesPage 274 of 384 (38,349 total)
  • T46.1X4DBillable

    Poisoning by calcium-channel blockers, undetermined, subsequent encounter

  • T46.1X4SBillable

    Poisoning by calcium-channel blockers, undetermined, sequela

  • T46.1X5DBillable

    Adverse effect of calcium-channel blockers, subsequent encounter

  • T46.1X5SBillable

    Adverse effect of calcium-channel blockers, sequela

  • T46.1X6DBillable

    Underdosing of calcium-channel blockers, subsequent encounter

  • T46.1X6SBillable

    Underdosing of calcium-channel blockers, sequela

  • T46.2X1DBillable

    Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter

  • T46.2X1SBillable

    Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela

  • T46.2X2DBillable

    Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter

  • T46.2X2SBillable

    Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela

  • T46.2X3DBillable

    Poisoning by other antidysrhythmic drugs, assault, subsequent encounter

  • T46.2X3SBillable

    Poisoning by other antidysrhythmic drugs, assault, sequela

  • T46.2X4DBillable

    Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter

  • T46.2X4SBillable

    Poisoning by other antidysrhythmic drugs, undetermined, sequela

  • T46.2X5DBillable

    Adverse effect of other antidysrhythmic drugs, subsequent encounter

  • T46.2X5SBillable

    Adverse effect of other antidysrhythmic drugs, sequela

  • T46.2X6DBillable

    Underdosing of other antidysrhythmic drugs, subsequent encounter

  • T46.2X6SBillable

    Underdosing of other antidysrhythmic drugs, sequela

  • T46.3X1DBillable

    Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter

  • T46.3X1SBillable

    Poisoning by coronary vasodilators, accidental (unintentional), sequela

  • T46.3X2DBillable

    Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter

  • T46.3X2SBillable

    Poisoning by coronary vasodilators, intentional self-harm, sequela

  • T46.3X3DBillable

    Poisoning by coronary vasodilators, assault, subsequent encounter

  • T46.3X3SBillable

    Poisoning by coronary vasodilators, assault, sequela

  • T46.3X4DBillable

    Poisoning by coronary vasodilators, undetermined, subsequent encounter

  • T46.3X4SBillable

    Poisoning by coronary vasodilators, undetermined, sequela

  • T46.3X5DBillable

    Adverse effect of coronary vasodilators, subsequent encounter

  • T46.3X5SBillable

    Adverse effect of coronary vasodilators, sequela

  • T46.3X6DBillable

    Underdosing of coronary vasodilators, subsequent encounter

  • T46.3X6SBillable

    Underdosing of coronary vasodilators, sequela

  • T46.4X1DBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter

  • T46.4X1SBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela

  • T46.4X2DBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter

  • T46.4X2SBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela

  • T46.4X3DBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter

  • T46.4X3SBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela

  • T46.4X4DBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter

  • T46.4X4SBillable

    Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela

  • T46.4X5DBillable

    Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter

  • T46.4X5SBillable

    Adverse effect of angiotensin-converting-enzyme inhibitors, sequela

  • T46.4X6DBillable

    Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter

  • T46.4X6SBillable

    Underdosing of angiotensin-converting-enzyme inhibitors, sequela

  • T46.5X1DBillable

    Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter

  • T46.5X1SBillable

    Poisoning by other antihypertensive drugs, accidental (unintentional), sequela

  • T46.5X2DBillable

    Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter

  • T46.5X2SBillable

    Poisoning by other antihypertensive drugs, intentional self-harm, sequela

  • T46.5X3DBillable

    Poisoning by other antihypertensive drugs, assault, subsequent encounter

  • T46.5X3SBillable

    Poisoning by other antihypertensive drugs, assault, sequela

  • T46.5X4DBillable

    Poisoning by other antihypertensive drugs, undetermined, subsequent encounter

  • T46.5X4SBillable

    Poisoning by other antihypertensive drugs, undetermined, sequela

  • T46.5X5DBillable

    Adverse effect of other antihypertensive drugs, subsequent encounter

  • T46.5X5SBillable

    Adverse effect of other antihypertensive drugs, sequela

  • T46.5X6DBillable

    Underdosing of other antihypertensive drugs, subsequent encounter

  • T46.5X6SBillable

    Underdosing of other antihypertensive drugs, sequela

  • T46.6X1DBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter

  • T46.6X1SBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela

  • T46.6X2DBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter

  • T46.6X2SBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela

  • T46.6X3DBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter

  • T46.6X3SBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela

  • T46.6X4DBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter

  • T46.6X4SBillable

    Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela

  • T46.6X5DBillable

    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter

  • T46.6X5SBillable

    Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela

  • T46.6X6DBillable

    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter

  • T46.6X6SBillable

    Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela

  • T46.7X1DBillable

    Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter

  • T46.7X1SBillable

    Poisoning by peripheral vasodilators, accidental (unintentional), sequela

  • T46.7X2DBillable

    Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter

  • T46.7X2SBillable

    Poisoning by peripheral vasodilators, intentional self-harm, sequela

  • T46.7X3DBillable

    Poisoning by peripheral vasodilators, assault, subsequent encounter

  • T46.7X3SBillable

    Poisoning by peripheral vasodilators, assault, sequela

  • T46.7X4DBillable

    Poisoning by peripheral vasodilators, undetermined, subsequent encounter

  • T46.7X4SBillable

    Poisoning by peripheral vasodilators, undetermined, sequela

  • T46.7X5DBillable

    Adverse effect of peripheral vasodilators, subsequent encounter

  • T46.7X5SBillable

    Adverse effect of peripheral vasodilators, sequela

  • T46.7X6DBillable

    Underdosing of peripheral vasodilators, subsequent encounter

  • T46.7X6SBillable

    Underdosing of peripheral vasodilators, sequela

  • T46.8X1DBillable

    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter

  • T46.8X1SBillable

    Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela

  • T46.8X2DBillable

    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter

  • T46.8X2SBillable

    Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela

  • T46.8X3DBillable

    Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter

  • T46.8X3SBillable

    Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela

  • T46.8X4DBillable

    Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter

  • T46.8X4SBillable

    Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela

  • T46.8X5DBillable

    Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter

  • T46.8X5SBillable

    Adverse effect of antivaricose drugs, including sclerosing agents, sequela

  • T46.8X6DBillable

    Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter

  • T46.8X6SBillable

    Underdosing of antivaricose drugs, including sclerosing agents, sequela

  • T46.901DBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter

  • T46.901SBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela

  • T46.902DBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter

  • T46.902SBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela

  • T46.903DBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter

  • T46.903SBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela

  • T46.904DBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter

  • T46.904SBillable

    Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela

  • T46.905DBillable

    Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter

  • T46.905SBillable

    Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela